
1. aids treat news. 1999 mar 19;(no 315):1-4.

lipodystrophy: glaxo researchers suggest mechanisms, publish data.

james js.

aids: two posters research possible mechanisms lipid
abnormalities presented retroviruses conference. abnormalities 
appear associated protease inhibitor use patients. the
research based lipid biochemistry, since many conference were
unfamiliar concept, posters poorly received. difficulty 
researching problem pharmaceutical companies inclined to
highlight problems associated drugs. amprenavir (agenerase), from
glaxo wellcome, associated almost lipid abnormalities among 
1,500 patients expanded-access program, long-term studies been
completed issue. one certain causes lipodystrophy, the
fundamental problem loss subcutaneous fat, results abnormal fat 
deposits body. two potential mechanisms avoiding problem are
preventing development fat cells increasing retinoid toxicity. both
theories described.

pmid: 11366558  [indexed medline]

